90113-41-0Relevant articles and documents
Kay,Perkin
, p. 372 (1907)
COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 615, (2015/02/02)
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.